FRISH ADI

PrivateCIK: 2113141

FRISH ADI enters REDHILL BIOPHARMA LTD. with 276.81M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderFRISH ADICIK 2113141
IssuerREDHILL BIOPHARMA LTD.CIK 1553846
Officer· Chief Corp & BD Officer
Since Mar 2026
276.81M
Baseline shares
100% direct
276.81M
Direct ownership
1 position
64.77M
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned276.81M
Total
276.81M direct276.81M
Derivative Holdings5

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

370K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

250K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

600K

Shares owned

N/A

Exercise price

Expiration

Exercise window

American Depositary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

62.80M

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

750K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Total

Underlying

64.77M

Owned

0.00